Post-effective amendment to a registration statement that is not immediately effective upon filing

SHARE-BASED COMPENSATION (Tables)

v3.22.1
SHARE-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2021
Equity [Abstract]  
Schedule of common stock reserved for future issuance under employee stock plans
       
Plans   Number of Shares  
Total awards available to be issued     3,059,623  
Total awards outstanding     8,452,376  
Total Common Stock reserved for future issuance under employee stock plans     11,511,999  
Schedule of summarizes share-based compensation expense
               
    December 31,  
    2021     2020  
Research and development   $ 1,812     $ 854  
Sales and marketing     1,925       561  
General and administrative     6,759       1,172  
Cost of sales     81       56  
Total share-based compensation   $ 10,577     $ 2,643  
Schedule of fair value of the stock options assumptions
               
    Year Ended
December 31,
 
    2021     2020  
Weighted-average grant date price of our common stock (per share)   $ 3.99     $ 12.78  
Risk-free interest rate     1.19 %     0.55 %
Expected volatility     33.0 %     68.0 %
Expected term (in years)     5       5  
Expected dividend yield     %     %
Schedule of common stock options
                                 
      Number of Shares     Weighted Average Exercise Price     Weighted Average Remaining Contractual Life (Years)     Weighted-Average Grant Date Fair Value  
Outstanding, December 31, 2020       5,500,135     $ 3.99       6.79     $ 2.37
Granted       498,164       6.36               3.99
Exercised       (327,954 )     3.28               1.62
Forfeited       (96,167 )     5.39               2.88
Expired       (84,686 )     3.31               1.72
Outstanding, December 31, 2021(a)       5,489,492     $ 4.23       6.05     $ 2.27
Exercisable, December 31, 2021(b)       3,939,056     $ 3.85       5.24     $ 1.98

 

 
(a) The aggregate intrinsic value of all stock options outstanding as of December 31, 2021 was $2.2 million.
(b) The aggregate intrinsic value of all vested/exercisable stock options as of December 31, 2021 was $2.2 million.
Schedule of restricted stock awards
                 
      Number of
Shares
    Weighted Average
Grant Date
Fair Value
 
Outstanding (nonvested), December 31, 2020       337,187     $ 3.83  
Granted       371,037       9.51  
Forfeited       (356,393 )     4.04  
Outstanding (nonvested), December 31, 2021       351,831     $ 9.63  
Schedule of restricted stock units
                 
      Number of
RSUs
    Weighted Average
Grant Date
Fair Value
 
Outstanding (nonvested), December 31, 2020           $  
Granted       2,964,884       8.60  
Forfeited       (2,000 )     6.94  
Outstanding (nonvested), December 31, 2021       2,962,884     $ 8.60